Navigation Links
Germany, Japan and Russia Will be the First Markets to Experience Peak Cases in Several Commercially Significant Drug Markets
Date:12/4/2013

BURLINGTON, Mass., Dec. 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that over the next six decades prevalent cases of several diseases that represent commercially important opportunities for drug developers will peak and then decline. The Strategic Insights report entitled Timing Matters: Shifting Opportunities for Drug Developers as Global Populations Age, finds that Germany, Japan and Russia will be the first markets to experience a peak in cases of chronic obstructive pulmonary disease, major depressive disorder, age-related macular degeneration and Alzheimer's disease.

The report examines the peak cases phenomenon in key commercial disease markets of Brazil, urban China, Germany, Japan, Russia and the United States, and explores the interaction between population size, demographics and peak cases. Because markets are at different stages of the population aging, peak cases will be reached at different times across markets and diseases.

According to the report, diseases with a higher prevalence in younger populations are more sensitive to the reductive impact of aging populations. For example, prevalent cases of major depressive disorder will decline owing to aging demographics across five of the six markets examined.

"Disease populations — and therefore opportunities for drug developers — will continue to expand for diseases with their highest prevalence in older age-groups. For example, prevalent cases in Alzheimer's disease will increase by more than 800 percent in urban China between 2012 and 2072," said Decision Resources Senior Epidemiologist Donal Minihan, Ph.D. "The United States is largely immune to the peak cases phenomenon because its immigration and reproductive rate will maintain an increasing population with a balanced spread across age-groups."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
2. Medical Device Market Opportunities in Germany, 2012
3. PELOBIOTECH to Distribute ReachBios Products in Germany, Austria and Switzerland
4. TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan
5. Japanese Fund Moves Quickly to Invest in Promising Technology Against Malaria, Tuberculosis And Chagas Disease
6. The Japanese Embolization Particle Market Will Witness Significant Market Activity And Rapid Growth Due To New Product Approvals
7. The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many Segments
8. Japan Pharmaceutical Market Outlook
9. Japan Vietnam Medical Instrument Company Ranked as One of Top 3 Companies in Vietnam
10. Japan Vietnam Medical Instrument Company Announces $7M Capital Raise
11. Japanese Heart Valve Device Market Growth Will Spike With The Launch of Transcatheter Heart Valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):